Reset Pharmaceuticals (Series A)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$60,000,000
Company Info
Founders
Jan-Anders Karlsson
Market
Healthcare & Wellness
Coinvestors
Palo Santo
Company Description

Reset Pharma is a privately-held biotechnology company focused on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.